
Sign up to save your podcasts
Or


Dr Rebecca Dent from National Cancer Centre Singapore and Dr Nancy Lin from Dana-Farber Cancer Institute in Boston, Massachusetts, discuss important efficacy and safety data from 2024 related to the management of localized and advanced breast cancers.
CME information and select publications here.
By Dr. Neil Love4.4
6262 ratings
Dr Rebecca Dent from National Cancer Centre Singapore and Dr Nancy Lin from Dana-Farber Cancer Institute in Boston, Massachusetts, discuss important efficacy and safety data from 2024 related to the management of localized and advanced breast cancers.
CME information and select publications here.

138 Listeners

324 Listeners

498 Listeners

30 Listeners

76 Listeners

14 Listeners

17 Listeners

12 Listeners

0 Listeners

120 Listeners

57 Listeners

295 Listeners

3,363 Listeners

204 Listeners

515 Listeners

59 Listeners

193 Listeners

0 Listeners